{"actinic keratosis": 32.73, "acute graft versus host disease": 20.99, "acute graft versus host disease in intestine": 28.99, "acute graft versus host disease in liver": 62.87, "acute graft versus host disease in skin": 35.27, "acute kidney injury": 2.65, "acute respiratory distress syndrome": 4.39, "adenovirus infection": 17.97, "adjustment disorder with depressed mood": 24.1, "agranulocytosis": 2.04, "anti-cyclic citrullinated peptide antibody positive": 12.74, "anti-erythropoietin antibody negative": 120.41, "aplasia pure red cell": 10.31, "arthropathy": 3.45, "aspergillus infection": 27.01, "autoimmune disorder": 6.3, "bacteraemia": 10.42, "bacterial infection": 6.79, "bacterial sepsis": 18.55, "basal cell carcinoma": 5.3, "bk virus infection": 64.63, "blood cholesterol increased": 4.05, "blood creatinine increased": 5.01, "blood urea increased": 2.39, "bowen's disease": 59.45, "brain abscess": 18.16, "bronchopulmonary aspergillosis": 25.8, "bursitis": 4.26, "c-reactive protein": 40.6, "c-reactive protein abnormal": 13.26, "c-reactive protein increased": 2.19, "chronic allograft nephropathy": 85.69, "chronic graft versus host disease": 27.96, "clostridium difficile colitis": 6.01, "clostridium difficile infection": 2.72, "complications of transplanted kidney": 97.43, "condition aggravated": 2.07, "contraindicated product administered": 3.17, "covid-19 pneumonia": 3.54, "cryptococcosis": 32.24, "cushingoid": 16.25, "cystitis haemorrhagic": 9.08, "cytomegalovirus colitis": 53.45, "cytomegalovirus infection": 52.59, "cytomegalovirus infection reactivation": 38.14, "cytomegalovirus test positive": 28.5, "cytomegalovirus viraemia": 77.1, "deep vein thrombosis postoperative": 88.26, "delayed graft function": 147.59, "diffuse large b-cell lymphoma": 5.65, "disseminated tuberculosis": 22.02, "drug ineffective for unapproved indication": 2.72, "drug interaction": 4.04, "drug intolerance": 2.26, "drug level increased": 6.43, "drug resistance": 3.23, "duodenal ulcer perforation": 22.36, "encephalitis": 3.66, "enterococcal infection": 20.74, "epstein-barr virus infection": 30.52, "epstein-barr virus infection reactivation": 10.35, "escherichia infection": 17.49, "febrile neutropenia": 2.33, "fibromyalgia": 3.53, "folliculitis": 6.62, "fungal infection": 9.66, "gastrointestinal disorder": 2.39, "graft versus host disease": 15.35, "graft versus host disease in gastrointestinal tract": 35.53, "graft versus host disease in skin": 33.58, "haemolytic anaemia": 2.54, "haemophagocytic lymphohistiocytosis": 6.53, "hand deformity": 3.56, "heart transplant rejection": 338.28, "helicobacter infection": 8.92, "hepatitis c": 5.03, "hepatitis e": 31.02, "histoplasmosis disseminated": 100.52, "human herpesvirus 6 infection": 48.82, "hypercholesterolaemia": 4.05, "hyperkalaemia": 2.81, "hypoxia": 2.31, "immunosuppressant drug level decreased": 38.08, "immunosuppressant drug level increased": 35.2, "immunosuppression": 5.82, "impaired healing": 4.44, "infection": 2.7, "infection reactivation": 41.29, "intentional product use issue": 2.33, "kaposi's sarcoma": 36.75, "kidney fibrosis": 35.27, "kidney transplant rejection": 66.6, "klebsiella infection": 33.52, "leukopenia": 6.12, "liver injury": 2.5, "liver transplant rejection": 41.45, "lung infiltration": 3.68, "lung transplant rejection": 53.24, "lymphopenia": 3.98, "meningitis cryptococcal": 23.54, "mucormycosis": 42.02, "multiple organ dysfunction syndrome": 5.37, "myopathy": 5.03, "necrotising fasciitis": 17.61, "nephropathy toxic": 9.13, "nephrotic syndrome": 5.61, "neutropenia": 2.87, "nocardiosis": 74.54, "off label use": 2.98, "pancytopenia": 3.4, "parvovirus b19 infection": 88.28, "peritonitis": 4.26, "pneumocystis jirovecii pneumonia": 26.45, "pneumonia": 2.42, "pneumonia bacterial": 5.83, "pneumonia cytomegaloviral": 44.47, "polyomavirus viraemia": 46.07, "polyomavirus-associated nephropathy": 136.5, "post transplant lymphoproliferative disorder": 71.62, "posterior reversible encephalopathy syndrome": 6.35, "product use in unapproved indication": 6.15, "progressive multifocal leukoencephalopathy": 8.76, "proteinuria": 4.77, "pseudomonas infection": 17.1, "pulmonary mass": 3.31, "pulmonary tuberculosis": 12.68, "pyelonephritis": 4.01, "renal impairment": 3.27, "renal transplant failure": 75.38, "renal tubular necrosis": 12.97, "respiratory distress": 2.0, "respiratory failure": 3.57, "sepsis": 4.11, "septic shock": 8.16, "skin lesion": 3.86, "skin mass": 5.38, "smooth muscle cell neoplasm": 166.58, "squamous cell carcinoma": 5.58, "squamous cell carcinoma of skin": 32.34, "staphylococcal infection": 5.41, "strongyloidiasis": 66.16, "therapy non-responder": 4.52, "thrombotic microangiopathy": 10.44, "transplant failure": 26.16, "transplant rejection": 100.17, "treatment failure": 2.09, "tuberculosis": 4.49, "tubulointerstitial nephritis": 3.29, "urinary tract infection": 2.46, "varicella zoster virus infection": 22.31, "viral haemorrhagic cystitis": 50.7, "wound infection": 11.07}